SERD
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
October, 2024
October 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Sep
SERD
Oct 17, 2024, 17:22 |
Blog
Brain Penetration Impeded SERD Efficacy in Breast Cancer Pre-Clinical Models
Stephanie Graff, Director of the Breast Oncology Program at Lifespan Cancer Institute at the Legorreta…
Jun 7, 2024, 09:11 |
Insight
Erika Hamilton: Happy to share the publication in Annals of Oncology
Erika Hamilton shared a post on X: “Happy to share the publication in Annals of…
May 19, 2024, 14:11 |
Societies
20 Posts Not To Miss From ESMOBreast24!
ESMO Breast Cancer 2024 (ESMOBreast24) took place as an onsite and online event in Berlin,…
May 17, 2024, 15:13 |
Societies
Elisabetta Munzone: TIP poster PREcoopERA trial for premenopausal women with early breast cancer
Elisabetta Munzone, Medical oncologist and Breast Cancer specialist at the European Institute of Oncology, shared…
Jul 23, 2023, 16:19 |
Blog
The first oral SERD gets closer to Europe - Paolo Tarantino
Positive CHMP opinion on the marketing authorization of elacestrant for patients with HR+/HER2- MBC with…
All:
5
Posts:
1 - 100
Making Personal Experience a Political Priority: Insights from EU Commissioner Stella Kyriakides
Zolbetuximab is now approved by the US FDA
Highlights from NFCR’s GSAC24
SIOP Honoured Hansjörg Riehm with the 2024 Lifetime Achievement Award
Margaret Foti has received the 2024 Beacon Award for Women Leaders in Oncology
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube